Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
Bladder Cancer · 26.04.2018 · 4 (2) · 169-183
DOI: 10.3233/blc-180167 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Bladder Cancer, online erschienen am 26.04.2018. Verfasst von Tahlita C M Zuiverloon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Bladder cancer (BC) cell lines are indispensable in basic and preclinical research. Currently, an up-to-date and comprehensive overview of available BC cell lines is not available.
Objective
To provide an overview and resources on the origin, pathological and molecular characteristics of commonly used human, murine and canine BC cell lines.
Methods
A PubMed search was performed for relevant articles published between 1980 and 2017 according to the following MeSH terms: cell line; cell line, tumor; urinary bladder neoplasms; carcinoma, transitional cell. The Cellosaurus database was searched, using the term “bladder” and/or “urothelial carcinoma”. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results
We provide information on 157 human, murine and canine BC cell lines. 103 human BC cell lines have molecular data available, of which 69 have been profiled by at least one “omic” technology. We outline how these cell lines are currently being used for in vitro and in vivo experimental models. These results allow direct comparison of BC cell lines to patient samples, providing information needed to make informed decisions on the most genomically appropriate cell line to answer research questions. Furthermore, we show that cross-contamination remains an issue and describe guidelines for prevention.
Conclusions
In the BC field, multiple human, murine and canine BC cell lines have been developed and many have become indispensable for in vitro and in vivo research. High-throughput -omic technologies have dramatically increased the amount of molecular data on these cell lines. We synthesized a comprehensive overview of these data as a resource for the BC scientific community.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Surgery (Urology), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.
- Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Zitieren
APA
Zuiverloon, T. C. M., de Jong, F. C., Costello, J. C., & Theodorescu, D. (2018). Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. Bladder Cancer, 4(2), 169-183. https://doi.org/10.3233/blc-180167
Vancouver
Zuiverloon TCM, de Jong FC, Costello JC, Theodorescu D. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. Bladder Cancer. 2018;4(2):169-183. doi:10.3233/blc-180167
BibTeX
@article{Zuiverloon2018,
author = {Zuiverloon, Tahlita C M and de Jong, Florus C and Costello, James C and Theodorescu, Dan},
title = {Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines},
journal = {Bladder Cancer},
year = {2018},
volume = {4},
number = {2},
pages = {169--183},
doi = {10.3233/blc-180167}
}
EUVIMED